Biblio
“Genome-wide association analysis of age-at-onset in Alzheimer's disease.”, Mol Psychiatry, vol. 17, no. 12, pp. 1340-6, 2012.
, “Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.”, Am J Hum Genet, vol. 83, no. 5, pp. 623-32, 2008.
, “Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.”, Mol Psychiatry, 2021.
, “Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.”, PLoS Genet, vol. 10, no. 9, p. e1004606, 2014.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.”, Nat Genet, vol. 41, no. 10, pp. 1088-93, 2009.
, “Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 1, pp. 35-43, 2009.
, “Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.”, PLoS Genet, vol. 10, no. 10, p. e1004758, 2014.
, “Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.”, Alzheimers Dement, vol. 12, no. 1, pp. 2-10, 2016.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Genomics in neurological disorders.”, Genomics Proteomics Bioinformatics, vol. 12, no. 4, pp. 156-63, 2014.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, “Heritability of the shape of subcortical brain structures in the general population.”, Nat Commun, vol. 7, p. 13738, 2016.
, “High-throughput identification of long-range regulatory elements and their target promoters in the human genome.”, Nucleic Acids Res, vol. 41, no. 9, pp. 4835-46, 2013.
, “HIPPIE: a high-throughput identification pipeline for promoter interacting enhancer elements.”, Bioinformatics, vol. 31, no. 8, pp. 1290-2, 2015.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.”, PLoS Med, vol. 15, no. 1, p. e1002487, 2018.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.”, Cell, vol. 153, no. 3, pp. 707-20, 2013.
, “Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.”, J Med Genet, vol. 42, no. 10, pp. 787-92, 2005.
, “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
,